In this interview, Dr. Peter O’Toole Director of the Bioscience Technology Facility and Head of Imaging and Cytometry at University of York discusses trends in imaging technologies that are impacting drug discovery. Hear how label-free microscopy and multiplex imaging of tissues are enabling researchers to learn more about cell biology and how data these technologies may be correlated with other emerging techniques, such as mass spectrometry, to further understand drug mechanisms.

This video won the Life Sciences Video Interview of the Year in the 2017 Scientists' Choice Awards. Find out more about the awards here